Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...

First patient enrolled in NIH/NHLBI-sponsored Phase 1 Study of fostamatinib, Rigel's oral SYK inhibitor "Our Phase 1 study evaluating fostamatinib in patients with sickle cell disease is an ...

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by surgeon-scientists.

Research indicates that exposure to red light may reduce the risk of blood clots. This conclusion was drawn from a series of ...

neutrophil extracellular trap; NLRP3, NOD-like receptor 3; ROS, reactive oxygen species; SAA1, serum amyloid A1; STAT3, signal transducer and activator of transcription 3; TLR4, Toll-like receptor 4; ...

Preventing blood clots could be as simple as changing the wavelength of light exposure. Find out how this discovery could revolutionize thrombosis prevention.

Tumor heterogeneity remains a formidable obstacle in targeted cancer therapy, often leading to suboptimal treatment outcomes. This study presents an innovative approach that harnesses controlled ...

Studies reveal a connection between red light exposure and a reduced risk of blood clots, offering potential new insights for ...

Exposure to long-wavelength red light significantly reduced blood clot formation in both mice and human studies.

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School ...

Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Clinical ...

The complement system and neutrophils constitute the two main pillars of the host innate immune defense against infection by bacterial pathogens. Here, we identify T-Mac, a novel virulence factor of ...